Sickle Cell Foundation Nigeria (SCFN) has achieved a historic breakthrough by completing the first-of-its-kind Bone Marrow Transplant (BMT) in Nigeria and West Africa, using advanced technology and ...
EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...
Conference call planned for later in Q4 2024 to provide updates on NurOwn® program NEW YORK, Nov. 14, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: ...